YESCARTA
Google image searchProduct monograph
Active ingredient
axicabtagene ciloleucel, 200000000 CELLS/BAG
DIN: 02485648
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription / Schedule D
Company: GILEAD SCIENCES CANADA INC
Date: 27-NOV-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XL — Antineoplastic cell and gene therapy (ATC, ATC/DDD)
- L01XL03 — AXICABTAGENE CILOLEUCEL (ATC/DDD)
